Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM.

J Immunother Cancer. 2020 Mar;8(1). pii: e000337. doi: 10.1136/jitc-2019-000337. Review.

2.

ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma.

Belisario DC, Akman M, Godel M, Campani V, Patrizio MP, Scotti L, Hattinger CM, De Rosa G, Donadelli M, Serra M, Kopecka J, Riganti C.

Cells. 2020 Mar 6;9(3). pii: E647. doi: 10.3390/cells9030647.

3.

Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells.

Rolle F, Bincoletto V, Gazzano E, Rolando B, Lollo G, Stella B, Riganti C, Arpicco S.

Int J Pharm. 2020 Mar 3;580:119191. doi: 10.1016/j.ijpharm.2020.119191. [Epub ahead of print]

PMID:
32142738
4.

From single gene analysis to single cell profiling: a new era for precision medicine.

Di Martino MT, Meschini S, Scotlandi K, Riganti C, De Smaele E, Zazzeroni F, Donadelli M, Leonetti C, Caraglia M.

J Exp Clin Cancer Res. 2020 Mar 5;39(1):48. doi: 10.1186/s13046-020-01549-3.

5.

Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells.

Cordani M, Butera G, Pacchiana R, Masetto F, Mullappilly N, Riganti C, Donadelli M.

Biomolecules. 2020 Feb 26;10(3). pii: E361. doi: 10.3390/biom10030361. Review.

6.

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells.

Fathy Abd-Ellatef GE, Gazzano E, Chirio D, Hamed AR, Belisario DC, Zuddas C, Peira E, Rolando B, Kopecka J, Assem Said Marie M, Sapino S, Ramadan Fahmy S, Gallarate M, Abdel-Hamid AZ, Riganti C.

Pharmaceutics. 2020 Jan 24;12(2). pii: E96. doi: 10.3390/pharmaceutics12020096.

7.

A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis.

Rosano S, Corà D, Parab S, Zaffuto S, Isella C, Porporato R, Hoza RM, Calogero RA, Riganti C, Bussolino F, Noghero A.

Elife. 2020 Jan 24;9. pii: e48095. doi: 10.7554/eLife.48095.

8.

Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R).

Spinelli F, Giampietro R, Stefanachi A, Riganti C, Kopecka J, Abatematteo FS, Leonetti F, Colabufo NA, Mangiatordi GF, Nicolotti O, Perrone MG, Brea J, Loza MI, Infantino V, Abate C, Contino M.

Eur J Med Chem. 2020 Feb 15;188:112037. doi: 10.1016/j.ejmech.2020.112037. Epub 2020 Jan 7.

PMID:
31954990
9.

Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.

Kopecka J, Trouillas P, Gašparović AČ, Gazzano E, Assaraf YG, Riganti C.

Drug Resist Updat. 2020 Mar;49:100670. doi: 10.1016/j.drup.2019.100670. Epub 2019 Nov 29. Review.

PMID:
31846838
10.

Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells.

Torrens-Mas M, Cordani M, Mullappilly N, Pacchiana R, Riganti C, Palmieri M, Pons DG, Roca P, Oliver J, Donadelli M.

Arch Biochem Biophys. 2020 Jan 15;679:108219. doi: 10.1016/j.abb.2019.108219. Epub 2019 Dec 5.

PMID:
31812668
11.

Applicability and Limitations in the Characterization of Poly-Dispersed Engineered Nanomaterials in Cell Media by Dynamic Light Scattering (DLS).

Marucco A, Aldieri E, Leinardi R, Bergamaschi E, Riganti C, Fenoglio I.

Materials (Basel). 2019 Nov 21;12(23). pii: E3833. doi: 10.3390/ma12233833.

12.

Combination of PDT and NOPDT with a Tailored BODIPY Derivative.

Lazzarato L, Gazzano E, Blangetti M, Fraix A, Sodano F, Picone GM, Fruttero R, Gasco A, Riganti C, Sortino S.

Antioxidants (Basel). 2019 Nov 7;8(11). pii: E531. doi: 10.3390/antiox8110531.

13.

From mitochondria to healthy aging: The role of branched-chain amino acids treatment: MATeR a randomized study.

Buondonno I, Sassi F, Carignano G, Dutto F, Ferreri C, Pili FG, Massaia M, Nisoli E, Ruocco C, Porrino P, Ravetta C, Riganti C, Isaia GC, D'Amelio P.

Clin Nutr. 2019 Oct 18. pii: S0261-5614(19)33085-7. doi: 10.1016/j.clnu.2019.10.013. [Epub ahead of print]

PMID:
31672329
14.

Mitochondrial metabolic alterations in cancer cells and related therapeutic targets.

Riganti C, Donadelli M.

Semin Cell Dev Biol. 2020 Feb;98:1-3. doi: 10.1016/j.semcdb.2019.10.005. Epub 2019 Oct 24. No abstract available.

PMID:
31668926
15.

Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma.

Castella B, Riganti C, Massaia M.

Front Biosci (Landmark Ed). 2020 Jan 1;25:69-105.

PMID:
31585878
16.

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer.

Riganti C, Contino M.

Int J Mol Sci. 2019 Sep 26;20(19). pii: E4783. doi: 10.3390/ijms20194783.

17.

Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.

Teodori E, Contino M, Riganti C, Bartolucci G, Braconi L, Manetti D, Romanelli MN, Trezza A, Athanasios A, Spiga O, Perrone MG, Giampietro R, Gazzano E, Salerno M, Colabufo NA, Dei S.

Eur J Med Chem. 2019 Nov 15;182:111655. doi: 10.1016/j.ejmech.2019.111655. Epub 2019 Aug 30.

PMID:
31494468
18.

What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg.

Alexa-Stratulat T, Pešić M, Gašparović AČ, Trougakos IP, Riganti C.

Drug Resist Updat. 2019 Sep;46:100643. doi: 10.1016/j.drup.2019.100643. Epub 2019 Aug 23. Review.

PMID:
31493711
19.

Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.

Grasso S, Cangelosi D, Chapelle J, Alzona M, Centonze G, Lamolinara A, Salemme V, Angelini C, Morellato A, Saglietto A, Bianchi FT, Cabodi S, Salaroglio IC, Fusella F, Ognibene M, Iezzi M, Pezzolo A, Poli V, Di Cunto F, Eva A, Riganti C, Varesio L, Turco E, Defilippi P.

Cell Death Differ. 2020 Apr;27(4):1448. doi: 10.1038/s41418-019-0405-7.

PMID:
31488891
20.

Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug.

Sodano F, Lazzarato L, Rolando B, Spyrakis F, De Caro C, Magliocca S, Marabello D, Chegaev K, Gazzano E, Riganti C, Calignano A, Russo R, Rimoli MG.

Mol Pharm. 2019 Oct 7;16(10):4181-4189. doi: 10.1021/acs.molpharmaceut.9b00508. Epub 2019 Sep 12.

PMID:
31465230

Supplemental Content

Loading ...
Support Center